Polaris Group
TWSE:6550

Watchlist Manager
Polaris Group Logo
Polaris Group
TWSE:6550
Watchlist
Price: 50.5 TWD -0.98% Market Closed
Market Cap: 37.7B TWD
Have any thoughts about
Polaris Group?
Write Note

Relative Value

The Relative Value of one Polaris Group stock under the Base Case scenario is 3.09 TWD. Compared to the current market price of 50.5 TWD, Polaris Group is Overvalued by 94%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
3.09 TWD
Overvaluation 94%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
53
vs Industry
3
Median 3Y
6 109.2
Median 5Y
1 377
Industry
7.9
vs History
vs Industry
Median 3Y
-58.1
Median 5Y
-92.2
Industry
23.3
vs History
vs Industry
Median 3Y
-65.7
Median 5Y
-130
Industry
22.8
vs History
vs Industry
Median 3Y
-74.2
Median 5Y
-116.2
Industry
26.4
vs History
68
vs Industry
12
Median 3Y
7.8
Median 5Y
7.3
Industry
2.6
vs History
53
vs Industry
3
Median 3Y
5 514.6
Median 5Y
1 288.8
Industry
7.6
vs History
vs Industry
100
Median 3Y
30 065.4
Median 5Y
-6 078.8
Industry
9
vs History
vs Industry
Median 3Y
-57.9
Median 5Y
-99.9
Industry
4.7
vs History
vs Industry
Median 3Y
-50.7
Median 5Y
-82.2
Industry
4.3
vs History
vs Industry
Median 3Y
-59.3
Median 5Y
-122.5
Industry
6.4
vs History
vs Industry
Median 3Y
-53.4
Median 5Y
-93
Industry
4.2
vs History
68
vs Industry
21
Median 3Y
25.7
Median 5Y
22.1
Industry
4.7

Multiples Across Competitors

Competitors Multiples
Polaris Group Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KY
Polaris Group
TWSE:6550
37.6B TWD 1 071.5 -22.2 -18.8 -17.4
US
Abbvie Inc
NYSE:ABBV
333B USD 6.1 62.9 15.4 23.6
US
Amgen Inc
NASDAQ:AMGN
172.6B USD 5.6 55.1 19.5 35.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
128.7B USD 12.4 -262.7 28 29.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
110.9B USD 8.2 25.7 22.3 24.7
US
Gilead Sciences Inc
NASDAQ:GILD
108.9B USD 3.9 103.4 9.8 12.4
US
Epizyme Inc
F:EPE
94.1B EUR 1 923 -490.7 -534.4 -520.1
AU
CSL Ltd
ASX:CSL
145.3B AUD 6.6 36.8 22.5 28
US
Seagen Inc
F:SGT
39.3B EUR 18.5 -56.8 -61.1 -55.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
38B USD 16.2 -521.2 230.2 354.4
KY
Beigene Ltd
SSE:688235
250.9B CNY 11.3 -57.4 -35.6 -35.6
P/E Multiple
Earnings Growth
KY
Polaris Group
TWSE:6550
Average P/E: 56.8
Negative Multiple: -22.2
N/A
US
Abbvie Inc
NYSE:ABBV
62.9
406%
US
Amgen Inc
NASDAQ:AMGN
55.1
74%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -262.7
38%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
25.7
56%
US
Gilead Sciences Inc
NASDAQ:GILD
103.4
71%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -490.7 N/A
AU
CSL Ltd
ASX:CSL
36.8
64%
US
S
Seagen Inc
F:SGT
Negative Multiple: -56.8 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -521.2 N/A
KY
Beigene Ltd
SSE:688235
Negative Multiple: -57.4 N/A
EV/EBITDA Multiple
EBITDA Growth
KY
Polaris Group
TWSE:6550
Average EV/EBITDA: 49.7
Negative Multiple: -18.8
N/A
US
Abbvie Inc
NYSE:ABBV
15.4
28%
US
Amgen Inc
NASDAQ:AMGN
19.5
64%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28
37%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
22.3
53%
US
Gilead Sciences Inc
NASDAQ:GILD
9.8
9%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -534.4 N/A
AU
CSL Ltd
ASX:CSL
22.5
42%
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.1 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
230.2
N/A
KY
Beigene Ltd
SSE:688235
Negative Multiple: -35.6 N/A
EV/EBIT Multiple
EBIT Growth
KY
Polaris Group
TWSE:6550
Average EV/EBIT: 72.6
Negative Multiple: -17.4
N/A
US
Abbvie Inc
NYSE:ABBV
23.6
88%
US
Amgen Inc
NASDAQ:AMGN
35.3
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
29.4
44%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
24.7
54%
US
Gilead Sciences Inc
NASDAQ:GILD
12.4
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -520.1 N/A
AU
CSL Ltd
ASX:CSL
28
55%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.1 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
354.4
N/A
KY
Beigene Ltd
SSE:688235
Negative Multiple: -35.6 N/A

See Also

Discover More
Back to Top